BioNTech

BioNTech vaccine hearing postponed after petition to change judge

By Nette Noestlinger HAMBURG, June 12 (Reuters) - The first hearing in a German court case against BioNTech over side effects allegedly caused by its COVID-19 vaccine was postponed on…

Read More Here

BioNTech faces first German lawsuit over alleged COVID vaccine side effects

By Ludwig Burger and Patricia Weiss HAMBURG, June 11 (Reuters) - BioNTech 22UAy.DE will go to court on Monday to defend itself against a lawsuit from a German woman who…

Read More Here

Pfizer, BioNTech propose EU pays half for each cancelled COVID dose – FT

April 30 (Reuters) - Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price,…

Read More Here

China to allow German expats to use German COVID-19 vaccines

BEIJING, Dec 10 (Reuters) - The Chinese foreign ministry said China and Germany had reached an agreement on providing "German vaccines" to German nationals in China, after the German Chancellor recently said…

Read More Here

Pfizer/BioNTech Omicron booster shows strong response after a month

Nov 4 (Reuters) - U.S. drugmaker Pfizer Inc and its German partner BioNTech said on Friday their Omicron-tailored shot targeting the BA.4/5 subvariants produced a strong antibody response in humans…

Read More Here

Pfizer, BioNTech start COVID-flu combination vaccine study

Nov 3 (Reuters) - U.S. drugmaker Pfizer Inc and its German partner BioNTech have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said…

Read More Here

Pfizer says updated booster protects against circulating COVID variants

Oct 13 (Reuters) - Pfizer Inc and its German partner BioNTech said on Thursday that their Omicron-adapted COVID-19 vaccine booster generated a strong immune response against the currently circulating BA.5…

Read More Here

BioNTech to expand trial programme for more anti-Omicron vaccine options

FRANKFURT, March 30 (Reuters) - BioNTech expanded an ongoing clinical trial programme to develop new vaccines and patterns of administration for better protection against the dominant Omicron coronavirus variant. The enlargement of its trial programme with…

Read More Here

BioNTech pledges African access to its future cancer drugs

Feb 16 (Reuters) - Germany's BioNTech , which is preparing to produce its COVID-19 vaccine or other disease-preventing shots in Africa, said that novel cancer therapies it is working on will in future…

Read More Here

BioNTech says developed method to detect high-risk variants

German COVID-19 vaccine maker BioNTech said it developed a method to quickly determine whether a new virus variant is a cause for concern, collaborating with British artificial intelligence startup InstaDeep…

Read More Here

BioNTech CEO says possible to adapt vaccine quickly for Omicron

FRANKFURT, Dec 3 (Reuters) - Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, its CEO Ugur Sahin said, adding that…

Read More Here

Pfizer/BioNTech, Moderna expect data on shot’s protection against new COVID-19 variant soon

FRANKFURT, Nov 26 (Reuters) - BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine…

Read More Here

UPDATED: BioNTech says expect more data on new variant in 2 weeks

FRANKFURT, Nov 26 (Reuters) - BioNTech, the inventor of the western world's most widely used COVID-19 vaccine, said it expects more laboratory data on a new worrying coronavirus variant detected…

Read More Here

Germany holds onto Biontech jabs as its Moderna stock risks expiry- report

Germany’s government will limit shipments of the Biontech/PfizerCOVID-19 vaccine in the coming weeks to push the use of its stock of Moderna vaccines before it expires, a health official was…

Read More Here

Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children

NEW YORK, Oct 21 (Reuters) - The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of five to 11 year olds, the U.S. drugmaker said…

Read More Here

Pfizer, BioNTech report high efficacy of COVID-19 booster shot in study

BERLIN, Oct 21 (Reuters) - Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their…

Read More Here

Hong Kong panel advises single dose of BioNTech COVID shot for teens

HONG KONG, Sept 16 (Reuters) - A panel of health experts advising the Hong Kong government has recommended children aged 12-17 should get only one dose of BioNTech's COVID-19 vaccine…

Read More Here

BioNTech to seek approval soon for vaccine for 5-11 year olds

BioNTech is set to request approval across the globe to use its COVID-19 vaccine in children as young as five over the next few weeks and preparations for a launch…

Read More Here

BioNTech eyes Rwanda, Senegal for malaria, tuberculosis vaccine production

COVID-19 vaccine maker BioNTech said it was looking into building malaria and tuberculosis vaccine production sites in Rwanda and Senegal, narrowing its search for African locations. The future malaria and…

Read More Here

BioNTech shots have stronger antibody response than Sinovac, Hong Kong study shows

People who are vaccinated against COVID-19 with BioNTech's vaccine were found to have "substantially higher" levels of antibodies than those who received Sinovac's jab, the South China Morning Post reported…

Read More Here

Study suggests Pfizer jab recipients have lower antibodies targeting Indian variant

People who have received the Pfizer/BioNTech vaccine have fewer antibodies targeting the Indian COVID-19 variant compared to other strains, new data suggests. Levels of these antibodies are lower with increasing…

Read More Here

Taiwan says China blocked deal with BioNTech for COVID-19 shots

Taiwan directly accused China for the first time on Wednesday of blocking a deal with Germany's BioNTech SE for COVID-19 vaccines, in an escalating war of words after Beijing offered…

Read More Here

BioNTech to build mRNA vaccine manufacturing site in Singapore

BioNTech plans to set up a regional centre and a new factory in Singapore for its vaccines, it said on Monday, boosting its presence in Asia as a debate over…

Read More Here

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

LONDON (Reuters) - BioNTech is working on getting approval for a version of its COVID-19 vaccine which can be stored in fridges of 2 to 8 degree celsius for up…

Read More Here

EU seals deal with Pfizer-BioNTech for up to 1.8 bln doses of vaccine – EU official

PUURS, Belgium, April 23 (Reuters) - The European Union has sealed the world's biggest vaccine supply deal, agreeing to buy up to 1.8 billion doses of the COVID-19 vaccine developed…

Read More Here

EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022 -EU source

BRUSSELS, April 9 (Reuters) - The European Commission is seeking EU governments' approval to launch talks with Pfizer and BioNTech for the purchase of up to 1.8 billion doses of…

Read More Here

BioNTech investigating packaging issue affecting Hong Kong, Macau

Germany's BioNTech said it was investigating a packaging issue in one production batch that has prompted a suspension of the use of its COVID-19 vaccine in Hong Kong and Macau.…

Read More Here

Europe can have immunity by summer’s end: BioNTech CEO

Europe can achieve herd immunity by the end of the summer with four vaccines approved by European health authorities, Ugur Sahin, a Turkish-German scientist and CEO of the BioNTech, said…

Read More Here

EU finalises second deal with Pfizer for 300 mln vaccine doses

BRUSSELS, Feb 8 (Reuters) - The European Union has finalised a deal with Pfizer and BioNTech for the supply of an additional 300 million doses of their COVID-19 vaccine, a…

Read More Here

BioNTech says back on schedule to deliver COVID-19 vaccine doses to EU

Feb 1 (Reuters) - BioNTech and Pfizer Inc are on-track to meet the delivery deadline for their coronavirus vaccine to the European Union, the Germany-based company said on Monday. European…

Read More Here

EU says Pfizer/BioNTech to deliver 75 million extra vaccine doses in second quarter

BRUSSELS, Feb 1 (Reuters) - Pfizer and German partner BioNTech will deliver 75 million extra doses of their COVID-19 vaccine in the second quarter of the year, European Commission President…

Read More Here

Italy says Pfizer to cut vaccine supplies by 29% from Monday

MILAN, Jan 15 (Reuters) - U.S. drugs firm Pfizer has told Italy it will cut its deliveries of vaccine shots against the novel coronavirus by 29% starting from Monday, the country's COVID-19…

Read More Here

BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion doses

Pfizer Inc's partner BioNTech SE has boosted the 2021 delivery target for their COVID-19 vaccine to 2 billion doses, up from 1.3 billion previously, as they add new production lines…

Read More Here

UPDATED: EU doubles COVID vaccine deal with Pfizer, EU countries cannot negotiate separate vaccine deals

The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the head of the European Commission said on Friday, in a…

Read More Here

UPDATED: EU in discussions with Pfizer-BioNTech for additional vaccine doses

The European Commission is in discussions with Pfizer and BioNTech about the possibility of ordering more doses of their COVID-19 vaccine, in addition to the 300 million shots already covered…

Read More Here

Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo

Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine…

Read More Here

BioNTech founders warn of vaccine supply gaps

BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled…

Read More Here

EXPLAINER – How does AstraZeneca’s vaccine compare with Pfizer-BioNTech?

ZURICH, Dec 30 (Reuters) - Britain on Wednesday became the first country to approve AstraZeneca and Oxford University's home-grown UK COVID-19 vaccine, adding an easy-to-manage shot to the arsenal of…

Read More Here

Italy approves Pfizer vaccine, France to approve it on December 24

PARIS (Reuters) - French medical regulator HAS said on Tuesday it would decide on Dec. 24 whether to approve the vaccine developed by Pfizer and BioNTech for France's vaccination rollout,…

Read More Here

How the Moderna vaccine stacks up against Pfizer/BioNTech’s

U.S. regulators authorized Moderna Inc’s COVID-19 vaccine for emergency use on Friday, a week after granting the first U.S. authorization to Pfizer Inc and BioNTech SE’s coronavirus shot. The following…

Read More Here

BioNTech says vaccine approval possible in mid-December under ideal conditions

U.S. and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said, following the release of positive trial results. Speaking…

Read More Here